Valuation: LeMaitre Vascular, Inc.

Market Cap 1.85B 1.62B 1.52B 1.39B 2.61B 177B 2.61B 18.26B 7.04B 90.41B 6.95B 6.8B 291B P/E 2026 *
28.2x
P/E 2027 * 25.5x
Enterprise Value 1.61B 1.41B 1.32B 1.21B 2.27B 154B 2.27B 15.89B 6.13B 78.67B 6.05B 5.92B 254B EV / Sales 2026 *
5.83x
EV / Sales 2027 * 5.12x
Free-Float
87.26%
Yield 2026 *
1.23%
Yield 2027 * 1.38%
1 week+1.45%
Current month+1.45%
3 months-10.26%
6 months-23.50%
1 week 68
Extreme 68
70.5
1 month 67
Extreme 67
70.5
3 years 42.4
Extreme 42.4
102
5 years 35.6
Extreme 35.6
102
Manager TitleAgeSince
Chief Executive Officer 61 01/06/1992
Director of Finance/CFO 51 10/03/2025
Director of Finance/CFO 62 01/01/2000
Director TitleAgeSince
Director/Board Member 68 01/01/2003
Chairman 61 01/01/2004
Director/Board Member 61 24/10/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.71%+1.45%-10.26%+32.08% 1.85B
-0.04%+2.67%+38.64%+30.97% 243B
+2.43%+5.60%+16.08%-10.98% 155B
+0.11%+6.61%-9.55%+39.52% 142B
+2.74%+2.39%-53.71%-16.19% 65.1B
+0.50%+3.55%+20.38%+27.45% 51.17B
-0.39%-2.71%-20.73%-21.02% 47.67B
+3.29%+11.31%+32.40%+50.13% 47.16B
+0.43%+2.07%+40.75%+58.27% 41.83B
+3.62%+11.32%+143.83%+86.85% 37.37B
Average +1.41%+4.91%+19.78%+27.71% 92.36B
Weighted average by Cap. +1.06%+4.50%+18.84%+22.69%

Financials

2026 *2027 *
Net sales 277M 242M 227M 207M 389M 26.44B 389M 2.73B 1.05B 13.5B 1.04B 1.02B 43.52B 303M 265M 249M 227M 426M 28.96B 426M 2.99B 1.15B 14.79B 1.14B 1.11B 47.68B
Net income 66.71M 58.3M 54.8M 50M 93.85M 6.38B 93.87M 658M 254M 3.26B 251M 245M 10.5B 74.29M 64.92M 61.02M 55.68M 105M 7.1B 105M 732M 283M 3.63B 279M 273M 11.69B
Net Debt -240M -210M -198M -180M -338M -22.99B -338M -2.37B -915M -11.74B -903M -883M -37.85B -300M -263M -247M -225M -423M -28.72B -423M -2.96B -1.14B -14.67B -1.13B -1.1B -47.28B
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
-
Date Price Change
23/09/26 EUR 70.50 +0.71%
22/09/26 EUR 70.00 +1.45%
21/09/26 EUR 69.00 +0.73%
18/09/26 EUR 68.50 -0.72%
17/09/26 EUR 69.00 -1.43%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.98USD
Average target price
107.00USD
Spread / Average Target
+32.13%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!